Field Trip Health Ltd. (CSE: FTRP) (OTCQB: FTRPF) Founder and Executive Chairman Ronan Levy tells Proactive the psychedelic therapies-focused group has been chosen as a trial location for a Multidisciplinary Association for Psychedelic Studies (MAPS) sponsored study. Levy says the non-profit research and educational organization will work with Field Trip to asses how MDMA may treat eating disorders, including anorexia and binge eating. Levy will pitch the company to KCSA Strategic Communications' psychedelic-focused investor conference January 26-27.
Field Trip Health chosen as trial location for MAPS-sponsored study to treat eating disorders with MDMA
